Catalpol promotes articular cartilage repair by enhancing the recruitment of endogenous mesenchymal stem cells
Journal of Cellular and Molecular Medicine · 2024
DOI: 10.1111/jcmm.18242 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Cellular and Molecular Medicine, 2024. Verfasst von Congzi Wu und 6 weiteren Autor:innen. Beteiligte Einrichtung: Institute of Orthopaedics and Traumatology of Zhejiang Province, The First Affiliated Hospital of Zhejiang Chinese Medical University (Zhejiang Provi…. Hauptthemen laut MEDLINE: Cartilage, Articular, Cartilage Diseases, Mesenchymal Stem Cells, Mesenchymal Stem Cell Transplantation. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 43 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Natural Science Foundation of China, Natural Science Foundation of Zhejiang Province.
Abstract (Originalsprache)
Articular cartilage defect is challenged by insufficient regenerative ability of cartilage. Catalpol (CA), the primary active component of Rehmanniae Radix, could exert protective effects against various diseases. However, the impact of CA on the treatment of articular cartilage injuries is still unclear. In this study, full‐thickness articular cartilage defect was induced in a mouse model via surgery. The animals were intraperitoneally injected with CA for 4 or 8 weeks. According to the results of macroscopic observation, micro‐computed tomography CT (μCT), histological and immunohistochemistry staining, CA treatment could promote mouse cartilage repair, resulting in cartilage regeneration, bone structure improvement and matrix anabolism. Specifically, an increase in the expression of CD90, the marker of mesenchymal stem cells (MSCs), in the cartilage was observed. In addition, we evaluated the migratory and chondrogenic effects of CA on MSCs. Different concentration of CA was added to C3H10 T1/2 cells. The results showed that CA enhanced cell migration and chondrogenesis without affecting proliferation. Collectively, our findings indicate that CA may be effective for the treatment of cartilage defects via stimulation of endogenous MSCs.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Institute of Orthopaedics and Traumatology of Zhejiang Province, The First Affiliated Hospital of Zhejiang Chinese Medical University (Zhejiang Provincial Hospital of Chinese Medicine), Hangzhou, Zhejiang, China.
- The First College of Clinical Medicine, Zhejiang Chinese Medical University, Hangzhou, China.
- Department of Orthopaedic Surgery, The First Affiliated Hospital of Zhejiang Chinese Medical University, Hangzhou, China.
- Department of Orthopaedic Surgery, Tongde Hospital of Zhejiang Province, Hangzhou, China.
ORCID-Profile: Hongting Jin
Förderung
- National Natural Science Foundation of China
- Natural Science Foundation of Zhejiang Province
Zitieren
APA
Wu, C., Shi, Z., Ge, Q., Xu, H., Wu, Z., Tong, P., & Jin, H. (2024). Catalpol promotes articular cartilage repair by enhancing the recruitment of endogenous mesenchymal stem cells. Journal of Cellular and Molecular Medicine. https://doi.org/10.1111/jcmm.18242
Vancouver
Wu C, Shi Z, Ge Q, Xu H, Wu Z, Tong P, et al. Catalpol promotes articular cartilage repair by enhancing the recruitment of endogenous mesenchymal stem cells. Journal of Cellular and Molecular Medicine. 2024. doi:10.1111/jcmm.18242
BibTeX
@article{Wu2024,
author = {Wu, Congzi and Shi, Zhenyu and Ge, Qinwen and Xu, HuiHui and Wu, Zhen and Tong, Peijian and Jin, Hongting},
title = {Catalpol promotes articular cartilage repair by enhancing the recruitment of endogenous mesenchymal stem cells},
journal = {Journal of Cellular and Molecular Medicine},
year = {2024},
doi = {10.1111/jcmm.18242}
}
EUVIMED